Elbit Med Tech Cash Flow-to-Debt Ratio
Elbit Med Tech cash flow-to-debt ratio. Elbit Med Tech (EMTC) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2021, meaning its operating cash flow of ILA-116.00K could theoretically repay 0% of its total liabilities (ILA38.54 Million) in one year. Check EMTC cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Elbit Med Tech (2008–2022)
Cash flow-to-debt ratio of Elbit Med Tech from 2008 to 2022. Historical debt coverage capacity for Elbit Med Tech across 12 annual periods. Check how aggressively does Elbit Med Tech reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Elbit Med Tech Cash Flow-to-Debt Ratio by Year (2008–2022)
Elbit Med Tech cash flow-to-debt ratio by year from 2008 to 2022. Year-by-year debt coverage analysis for Elbit Med Tech. For the full cash flow conversion analysis, see Elbit Med Tech cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.01x | ILA-526.00K | ILA522.00K | ▼ -3.9% |
| 2021 | -0.97x | ILA-547.00K | ILA564.00K | ▼ -5219.8% |
| 2020 | -0.02x | ILA-674.00K | ILA36.97 Million | ▼ -61.2% |
| 2019 | -0.01x | ILA-571.00K | ILA50.48 Million | ▲ +1.3% |
| 2018 | -0.01x | ILA-499.00K | ILA43.52 Million | ▼ -61.8% |
| 2017 | -0.01x | ILA-301.00K | ILA42.48 Million | ▲ +10.1% |
| 2016 | -0.01x | ILA-293.00K | ILA37.18 Million | ▼ -2.7% |
| 2015 | -0.01x | ILA-261.00K | ILA34.00 Million | ▲ +43.6% |
| 2014 | -0.01x | ILA-443.00K | ILA32.56 Million | ▼ -36.9% |
| 2013 | -0.01x | ILA-336.00K | ILA33.82 Million | ▲ +83.2% |
| 2009 | -0.06x | ILA-9.38 Million | ILA158.28 Million | ▼ -1.4% |
| 2008 | -0.06x | ILA-10.79 Million | ILA184.65 Million | — |